Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.42M | -1.10M | -2.05M | -1.79M | -1.53M |
| Total Depreciation and Amortization | 56.60K | 79.80K | 101.40K | 98.80K | 96.10K |
| Total Amortization of Deferred Charges | 292.70K | 290.60K | 286.50K | 231.40K | 184.50K |
| Total Other Non-Cash Items | 3.43M | -736.50K | 284.50K | 359.20K | 360.10K |
| Change in Net Operating Assets | 588.90K | 381.40K | 210.90K | -22.20K | 33.40K |
| Cash from Operations | -1.05M | -1.09M | -1.16M | -1.12M | -852.50K |
| Capital Expenditure | 0.00 | 0.00 | -26.10K | -26.10K | -26.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -25.00K | -25.00K | -16.70K | 17.30K |
| Cash from Investing | 0.00 | -25.00K | -51.10K | -42.80K | -8.80K |
| Total Debt Issued | 1.42M | 1.59M | 1.72M | 1.73M | 1.57M |
| Total Debt Repaid | -446.40K | -469.90K | -526.20K | -558.80K | -630.20K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 970.60K | 1.12M | 1.19M | 1.17M | 940.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -79.00K | 8.00K | -24.30K | 3.50K | 79.00K |